10-Q quarterly report · filed Nov 12, 2026

Lucid Diagnostics Inc. (LUCD) Q3 2026 10-Q Quarterly Report

Short answer

Lucid Diagnostics Inc. (LUCD) filed its Q3 2026 10-Q quarterly report on Nov 12, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $1M (down 0.7% year over year) with net income of −$7M.

Q3 2026 key financials · XBRL

Revenue
$1M
−0.7% YoY · −18.5% QoQ
Net income
−$7M
+35.8% YoY · +42.9% QoQ
Operating margin
-1021.3%
EPS (diluted)
−$0.02
+71.4% YoY · +71.4% QoQ

Source: XBRL data from the Lucid Diagnostics Inc. (LUCD) Q3 2026 10-Q on SEC EDGAR. USD.

Lucid Diagnostics Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $1.2M, flat versus $1.2M in Q3 2025
  • Gross margin negative 16.7% versus negative 41.7% YoY, based on revenue and cost of revenue
  • Sales and marketing worst-performing expense line: $5.3M, up from $4.3M YoY
  • Cash $18.0M at September 30, 2026; operating cash use $38.9M for nine months
  • Series C preferred offering generated $15.0M gross proceeds; going-concern doubt and recurring losses remain near-term headwinds

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Lucid Diagnostics Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.